Contipro was established in 1990 and for almost 20 years the company has formed a holding of three companies. Contipro is one of the main world producers of hyaluronic acid. Its activities focus on the production of active substances for applications in cosmetics, pharmacy and medicine. Contipro’s R&D department is divided into 9 research groups comprised of organic chemistry, cell physiology, tissue engineering, carriers of drugs, nanoparticles, nanofibers and microfibers, medicinal applications and pilot plant section. There is also a specialised group focused on medical devices development. Contipro is involved in several national and European projects and has many research collaborations with other research centres, universities and companies. Contipro’s advanced manufacturing process allows maximizing quality, which is certified by the Czech State Institute for Drug Control (SIDC) and the American Institute for Food and Drug Administration (FDA).